Varenicline Tartrate Kit
Product Images NDC 42571-475

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Varenicline Tartrate (NDC 42571-475). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Varenicline-05mglbl.jpg (Varenicline 05mglbl)

Label for varenicline tartrate tablets, 0.5 mg strength, film-coated oral tablets. The label includes dosage information, storage instructions, and states the product is Rx only. It is manufactured by Micro Labs Limited in India and distributed by Micro Labs USA, Inc. The package contains 56 tablets with NDC 42571-459-82.*

FDA Label Image

Varenicline-1mglbl.jpg (Varenicline 1mglbl)

Label for varenicline tablets, 1 mg strength, film-coated oral tablets. The label notes each tablet contains 1.71 mg varenicline tartrate equivalent to 1 mg varenicline free base. Packaging contains 56 tablets. Manufactured by Micro Labs Limited, India, and labeled for Micro Labs USA, Inc. Storage and pharmacist dispensing instructions are included along with the NDC 42571-460-82.*

FDA Label Image

Varenicline-contpck460.jpg (Varenicline Contpck460)

Packaging label for Varenicline Tablets 1 mg by Micro Labs Limited. The label indicates it is a continuing pack containing 4 continuing weeks (56 tablets total) with directions for daily morning and evening doses. The label displays the NDC 42571-460-88 and includes storage instructions, manufacturer details, and a barcode.*

FDA Label Image

Varenicline-contpck4601.jpg (Varenicline Contpck4601)

Packaging label for Varenicline Tablets Continuing Month Box contains 56 film-coated tablets, each equivalent to 1 mg varenicline free base, enough for 4 weeks. Manufactured by Micro Labs Limited, India, and labeled for Micro Labs USA, Inc. The box instructs pharmacists to dispense the Medication Guide and indicates storage temperature instructions.*

FDA Label Image

Varenicline-figa.jpg (Varenicline Figa)

A bar chart comparing response rates across five clinical studies for varenicline tartrate tablets 0.5 mg and 1.0 mg twice daily, bupropion sustained-release 150 mg twice daily, and placebo. Error bars indicate variability in response percentages for each treatment group in studies 2 through 5.*

FDA Label Image

Varenicline-figb.jpg (Varenicline Figb)

A bar chart comparing the percentage outcomes of varenicline tablets 0.5 mg BID, varenicline tablets 1.0 mg BID, bupropion SR 150 mg BID, and placebo across five different studies. Each study compares drug treatments against placebo with error bars indicating variability. The chart visually represents efficacy results for varenicline tartrate and bupropion SR in oral tablet form.*

FDA Label Image

Varenicline-figc.jpg (Varenicline Figc)

A line graph showing the percentage of continuous abstinent subjects over nontreatment follow-up weeks, comparing Varenicline Tablets 1.0 mg BID to placebo. The y-axis represents percentage abstinent, and the x-axis shows weeks of follow-up. The graph depicts a decline in abstinence over time for both groups, with varenicline showing higher abstinence rates than placebo.*

FDA Label Image

Varenicline-img.jpg (Varenicline Img)

Chemical structure diagram of varenicline tartrate, showing molecular components and ring structures. The image depicts the detailed bonding arrangement of the active ingredient varenicline tartrate.*

FDA Label Image

Varenicline-strpck475.jpg (Varenicline Strpck475)

Varenicline Tablets Starting Pack blister card label with sections for Day 1 to Day 28 dosing. Contains 0.5 mg and 1 mg film-coated oral tablets. Label includes dosing schedule by day morning and evening, storage instructions, manufacturer Micro Labs Limited, and distributor Micro Labs USA, Inc. Packaging instructs use of the green Starting Week blister first.*

FDA Label Image

Varenicline-strpck4751.jpg (Varenicline Strpck4751)

Packaging label for Varenicline Tablets, a prescription oral film-coated tablet by Micro Labs Limited. This 'Starting Month Box' includes 0.5 mg and 1 mg tablet strengths, with instructions that the box contains 11 tablets of 0.5 mg and 42 tablets of 1 mg. The label includes storage instructions and dosage guidance for the initial four weeks of treatment.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.